STEERABLE GUIDE CATHETER SGC0302

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,foreig report with the FDA on 2020-03-11 for STEERABLE GUIDE CATHETER SGC0302 manufactured by Abbott Vascular.

Event Text Entries

[184445750] The reported device was not returned for analysis. A review of the lot history record revealed no manufacturing nonconformities. Additionally, a review of the complaint history identified no similar incidents reported from this lot. The reported patient effect of perforation, as listed in the mitraclip system instructions for use, is a known possible complication associated with mitraclip procedure. All available information was investigated and the cause for reported tear on the steerable guide catheter (sgc) soft tip could not be determined. Perforation appears to be related to procedural circumstances. There is no indication of a product quality issue with respect to manufacture, design or labeling. The additional mitraclip device referenced is being filed under a separate medwatch report.
Patient Sequence No: 1, Text Type: N, H10


[184445751] This is filed to report soft tip damage and atrial perforation. It was reported that this was a mitraclip procedure to treat degenerative mitral regurgitation (mr) with a grade of 3. An xtr clip delivery system (cds) (91113u102) was advanced and grasping was successfully performed, reducing mr. During deployment of the clip, the gripper line was pulled, but after retracting roughly 1. 3m, the gripper line became stuck. In an attempt to remove the gripper line, the physician decided to remove the cds. However, after removal of the cds, the gripper line was still unable to be removed. Therefore, the physician decided to remove the steerable guide catheter (sgc) (91022u160) and insert a multipurpose catheter to try and remove the gripper line. It was noted that upon removal of the sgc, a slight slit was visible on the soft tip. When attempting to remove the gripper line, addition force was applied, which caused mr to increase. The gripper line was unable to removed, so to reduce mr, an additional clip was implanted while using a separate sgc. The gripper line was left in the patient and a closure the device was used to close the atrial septal defect. There was no clinically significant delay in the procedure. No additional information was provided.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2024168-2020-02264
MDR Report Key9818642
Report SourceCOMPANY REPRESENTATIVE,FOREIG
Date Received2020-03-11
Date of Report2020-03-11
Date of Event2020-02-18
Date Mfgr Received2020-02-18
Device Manufacturer Date2019-10-22
Date Added to Maude2020-03-11
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. LINDSEY BELL
Manufacturer Street26531 YNEZ RD.
Manufacturer CityTEMECULA CA 925914628
Manufacturer CountryUS
Manufacturer Postal925914628
Manufacturer Phone9519143996
Manufacturer G1ABBOTT VASCULAR, REG # 3005070406
Manufacturer Street3885 BOHANNON DRIVE
Manufacturer CityMENLO PARK CA 94025
Manufacturer CountryUS
Manufacturer Postal Code94025
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameSTEERABLE GUIDE CATHETER
Generic NameVALVE REPAIR
Product CodeDRA
Date Received2020-03-11
Catalog NumberSGC0302
Lot Number91022U160
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerABBOTT VASCULAR
Manufacturer Address26531 YNEZ RD. TEMECULA CA 925914628 US 925914628


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2020-03-11

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.